Safety and Tolerability of Sub-retinal Transplantation of hESC Derived RPE (MA09-hRPE) Cells in Patients With Advanced Dry Age Related Macular Degeneration
Condition(s):Dry Age Related Macular DegenerationLast Updated:July 7, 2021Completed
Hide Studies Not Open or Pending
Condition(s):Dry Age Related Macular DegenerationLast Updated:July 7, 2021Completed
Condition(s):Dry Age-related Macular DegenerationLast Updated:February 24, 2021Completed
Condition(s):Dry Age-related Macular Degeneration; Vision Impairment and BlindnessLast Updated:March 22, 2023Not yet recruiting
Condition(s):Age-Related Macular DegenerationLast Updated:July 19, 2022Not yet recruiting
Condition(s):Dry Age Related Macular DegenerationLast Updated:October 9, 2017Unknown status
Condition(s):Age-related Macular Degeneration; Choroidal Neovascular Age-related Macular DegenerationLast Updated:January 20, 2014Completed
Condition(s):Age Related Macular DegenerationLast Updated:March 18, 2020Completed
Condition(s):Advanced Dry AMD With Geographic AtrophyLast Updated:July 1, 2013Completed
Condition(s):Dry Age-related Macular DegenerationLast Updated:January 26, 2024Active, not recruiting
Condition(s):Age Related Macular DegenerationLast Updated:December 14, 2020Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.